CVRx, Inc. (CVRX) Current Ratio
- Current ratio · latest quarter: Value 8.04×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 8.04× | Current assets / current liabilities. $89.49M ÷ $11.12M ≈ 8.04× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 89.49M USD | Assets, Current |
| Current obligations | 11.12M USD | Liabilities, Current |
| Cash and equivalents | 64.59M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 9.40M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory | 13.03M USD | Inventory, Net |
| Payables | 3.87M USD | Accounts Payable, Current |
| Borrowing debt due within one year | (m) | Long-term Debt, Current Maturities |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $89.49M | $11.12M | $64.59M | (m) | $9.40M | $13.03M | $3.87M | (m) | 8.04× |
| 2026-03-31 | $96.75M | $9.49M | $72.30M | (m) | $9.10M | $12.40M | $3.00M | (m) | 10.20× |
| 2025-12-31 | $101.65M | $13.32M | $75.71M | (m) | $10.66M | $12.21M | $3.83M | (m) | 7.63× |
| 2025-09-30 | $107.89M | $11.22M | $85.12M | (m) | $8.21M | $11.39M | $3.63M | (m) | 9.62× |
| 2025-06-30 | $116.14M | $9.69M | $95.03M | (m) | $7.15M | $11.72M | $3.03M | (m) | 11.99× |
| 2025-03-31 | $126.13M | $8.51M | $102.67M | (m) | $9.01M | $11.67M | $2.75M | (m) | 14.83× |
| 2024-12-31 | $129.81M | $10.76M | $105.93M | (m) | $9.27M | $12.11M | $2.58M | (m) | 12.06× |
| 2024-09-30 | $123.87M | $10.95M | $100.16M | (m) | $9.03M | $11.89M | $3.28M | (m) | 11.32× |
| 2024-06-30 | $91.99M | $9.13M | $70.40M | (m) | $8.61M | $11.22M | $3.52M | (m) | 10.08× |
| 2024-03-31 | $102.32M | $8.40M | $80.11M | (m) | $8.49M | $11.06M | $2.61M | (m) | 12.18× |
| 2023-12-31 | $112.09M | $7.86M | $90.57M | (m) | $7.55M | $10.98M | $1.88M | (m) | 14.25× |
| 2023-09-30 | $103.60M | $7.41M | $82.99M | (m) | $6.37M | $10.89M | $1.13M | (m) | 13.99× |
| 2023-06-30 | $112.01M | $8.93M | $90.81M | (m) | $6.73M | $10.93M | $2.93M | (m) | 12.55× |
| 2023-03-31 | $120.58M | $7.96M | $103.28M | (m) | $6.43M | $8.24M | $2.00M | (m) | 15.15× |
| 2022-12-31 | $122.88M | $8.09M | $106.19M | (m) | $5.50M | $6.96M | $1.72M | (m) | 15.19× |
| 2022-09-30 | $124.41M | $7.40M | $109.98M | (m) | $5.30M | $6.06M | $1.28M | (m) | 16.82× |
| 2022-06-30 | $131.94M | $5.91M | $121.35M | (m) | $3.60M | $5.83M | $608.00K | (m) | 22.33× |
| 2022-03-31 | $142.20M | $6.59M | $131.18M | (m) | $3.67M | $5.26M | $1.61M | (m) | 21.57× |
| 2021-12-31 | $151.10M | $5.91M | $142.07M | (m) | $2.56M | $3.88M | $510.00K | (m) | 25.57× |
| 2021-09-30 | $180.70M | $8.85M | $170.91M | (m) | $3.42M | $3.44M | $541.00K | $3.33M | 20.42× |
| 2021-06-30 | $54.22M | $25.04M | $47.13M | (m) | $2.24M | $3.16M | $888.00K | $1.33M | 2.16× |
| 2020-12-31 | $64.34M | $7.98M | $59.11M | (m) | $1.28M | $3.34M | $483.00K | (m) | 8.07× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |